Breaking news and analysis on the biotech industry — covering drug development, clinical trials, IPOs, M&A, and the companies pushing biopharma forward.
Scancell and Neuphoria have agreed to a reverse merger that will result in a Nasdaq listing for Scancell and a resolution for Neuphoria’s shareholders.
